Activities | Page 7 | OptumHealth Education

Title	Category	Credit	Event date	Cost
Normothermic Regional Perfusion	Disease management Transplantation	0.75 ACPE - Pharmacists 0.75 ACPE - Pharmacy Technicians 0.75 AMA - Physicians 0.75 ANCC - Nurses 0.75 APA - Psychologists 0.75 Attendance - General Attendance 0.75 CCMC - General - Case Managers 0.75 CDR - Dietitians 0.75 ASWB - Social Workers		$0.00	This activity will discuss the opportunities presented by NRP to increase the availability of donor organs and allow for extended patient survival time until transplant. The principles of NRP, effects on graft survival, potential complications, and ethical and legal concerns will be reviewed.
Social Determinants of Health in Cancer Care	Disease management Health equity Oncology	0.75 ACPE - Pharmacists 0.75 ACPE - Pharmacy Technicians 0.75 AMA - Physicians 0.75 ANCC - Nurses 0.75 APA - Psychologists 0.75 Attendance - General Attendance 0.75 CCMC - General - Case Managers 0.75 CDR - Dietitians 0.75 ASWB - Social Workers		$0.00	This activity will review the impact of poorer SDOH status on cancer care, disease progression, outcomes, access to treatment and many other aspects. It will also present care models, strategies and resources to help health care professionals best confront the challenges faced by many individuals with cancer.
Selecting Appropriate Treatments Based on Geriatric and Fragility Assessments	Disease management Older adults Oncology Transplantation	0.75 ACPE - Pharmacists 0.75 ACPE - Pharmacy Technicians 0.75 AMA - Physicians 0.75 ANCC - Nurses 0.75 APA - Psychologists 0.75 Attendance - General Attendance 0.75 CCMC - General - Case Managers 0.75 CDR - Dietitians 0.75 ASWB - Social Workers		$0.00	This activity will provide an overview of geriatric and frailty assessment tools that can assist in guiding cancer- and transplant-related decision making through the risk stratification of older individuals before therapy is initiated. Data surrounding the relationship among increased age, geriatric- and frailty-assessment results, and disease outcomes will also be explored. Key considerations in how to best incorporate these sometimes time-intensive assessments into practice will be outlined, along with discussion of how interprofessional collaboration among members of the health care team in the creation of care plans can facilitate quality care.
Implications for Transplantation in Acute-on-Chronic Liver Failure: Determining a Course of Action	Disease management Transplantation	0.75 ACPE - Pharmacists 0.75 ACPE - Pharmacy Technicians 0.75 AMA - Physicians 0.75 ANCC - Nurses 0.75 APA - Psychologists 0.75 Attendance - General Attendance 0.75 CCMC - General - Case Managers 0.75 CDR - Dietitians 0.75 ASWB - Social Workers		$0.00	This activity will help participants to better determine the role and optimal timing of liver transplant in ACLF. It will review precipitators of ACLF associated with poorer outcomes, including bacterial infections and hepatitis B virus, and will explore posttransplant outcomes and predictors. The accuracy of current scoring systems for assessing the severity of disease and predicting survival will be discussed, including the Model for End-stage Liver Disease (MELD) score and the Chronic Liver Failure Consortium Organ Failure (CLIF-C OF) score.
The Continuous Distribution Model: A New System for Organ Allocation	Disease management Transplantation	0.75 ACPE - Pharmacists 0.75 ACPE - Pharmacy Technicians 0.75 AMA - Physicians 0.75 ANCC - Nurses 0.75 APA - Psychologists 0.75 Attendance - General Attendance 0.75 CCMC - General - Case Managers 0.75 CDR - Dietitians 0.75 ASWB - Social Workers		$0.00	In this activity, participants will learn about the timeline for UNOS’s implementation of this flexible, points-based approach for all organ systems; how continuous distribution differs from the current system; and how this program is expected to benefit those who await organ transplant and impact future organ-allocation policy.
Islet Cell and Simultaneous Pancreas-Kidney Transplant	Disease management Transplantation	0.75 ACPE - Pharmacists 0.75 ACPE - Pharmacy Technicians 0.75 AMA - Physicians 0.75 ANCC - Nurses 0.75 APA - Psychologists 0.75 Attendance - General Attendance 0.75 CCMC - General - Case Managers 0.75 CDR - Dietitians 0.75 ASWB - Social Workers		$0.00	This activity will examine the safety and effectiveness of SPK and islet cell transplants in reversing hypoglycemia and achieving sustained insulin independence. Current advances in SPK and islet cell transplantation will be explored, along with complications, outcomes, patient management and post-transplant monitoring. The importance of coordination between health care professionals from multiple disciplines and specialties in facilitating transplantation success will be discussed.
Psychosocial Considerations in Post-Hematopoietic Stem Cell Transplantation	Behavioral health Disease management Oncology	0.75 ACPE - Pharmacists 0.75 ACPE - Pharmacy Technicians 0.75 AMA - Physicians 0.75 ANCC - Nurses 0.75 APA - Psychologists 0.75 Attendance - General Attendance 0.75 CCMC - General - Case Managers 0.75 CDR - Dietitians 0.75 ASWB - Social Workers		$0.00	This activity will discuss the current approach for screening and management of these complications and will review data regarding the negative associations among psychological distress, health outcomes, successful HSCT, and increased mortality. Barriers in the delivery of psychosocial care and care models to address these issues will also be outlined.
Advances in Gene Therapy for Sickle Cell Disease and Thalassemia	Disease management Oncology	0.75 ACPE - Pharmacists 0.75 ACPE - Pharmacy Technicians 0.75 AMA - Physicians 0.75 ANCC - Nurses 0.75 APA - Psychologists 0.75 Attendance - General Attendance 0.75 CCMC - General - Case Managers 0.75 CDR - Dietitians 0.75 ASWB - Social Workers		$0.00	This session will examine the genetic approaches being explored for these diseases, such as the introduction of a corrected or modified β-globin gene and gene-sequence editing. It will also explore the genetic modalities utilized, such as genome-editing technologies including the clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene-editing system and lentiviral vectors. The safety, efficacy and challenges associated with these therapies will also be outlined.
Emerging Applications of CAR T-cell Therapy in Cancer	Disease management Oncology	1.00 ACPE - Pharmacists 1.00 ACPE - Pharmacy Technicians 1.00 AMA - Physicians 1.00 ANCC - Nurses 1.00 APA - Psychologists 1.00 Attendance - General Attendance 1.00 CCMC - General - Case Managers 1.00 CDR - Dietitians 1.00 ASWB - Social Workers		$0.00	This activity will explore the most recent advances of this rapidly evolving therapy, including current data on its efficacy, limitations and challenges in the treatment of multiple myeloma and solid tumors. It will provide an overview of currently existing guidelines for CAR T-cell therapy and will describe best practices in determining individuals’ eligibility for this type of therapy, including factors that may affect treatment efficacy and outcomes.
A Closer Look at Novel Treatment Therapies for Acute Myeloid Leukemia	Disease management Oncology	0.75 ACPE - Pharmacists 0.75 ACPE - Pharmacy Technicians 0.75 AMA - Physicians 0.75 ANCC - Nurses 0.75 APA - Psychologists 0.75 Attendance - General Attendance 0.75 CCMC - General - Case Managers 0.75 CDR - Dietitians 0.75 ASWB - Social Workers		$0.00	This activity will discuss these novel agents’ indications, risks, and benefits and will address which patient populations are most likely to benefit from particular agents. In addition, early-phase clinical trials and emerging therapies will be explored.

Pages